摘要
目的 :研究4种脑梗塞药物治疗方案的经济效果。方法 :将190例脑梗塞患者分为A、B、C、D4组 ,运用药物经济学比较其成本 -效果。结果 :4种方案成本分别为2887 04元、4169 52元、4062 13元、4968 27元 ;有效率分别为69 39 %、87 27 %、71 43 %、76 92 %。在方案A的基础上 ,每再获得1个单位效果 ,方案B、C、D所需追加的成本依次为71 73元、576 02元、276 39元。结论 :B方案为较佳治疗方案。
OBJECTIVE:To discuss the economic effects of different therapeutic schemes for cerebral infarction.METHODS:190cases of cerebral infarction,admitted from1999to2003,were collected and divided into four groups:A.Dengzhanhua,B.Fonzylane,C.Dengzhanhua+anticoagulants or fibrinolytic,D.Fonzylane+anticoagulants or fibrinolytic.Data was evaluated using the pharmacoeconomic cost-effectiveness analysis.RESULTS:The costs of four groups were 2887.04,4169.52,4062.13and4968.27yuans respectively.The effective rates of four groups were69.39%,87.27%,71.43%and76.92%respectively.Compared with scheme A,scheme B,C,D costed71.73,576.02,276.39yuans respectively for further increasing1%effective rate.CONCLUSION:Among the four schemes,B is the best one.
出处
《中国药房》
CAS
CSCD
2004年第9期547-549,共3页
China Pharmacy
关键词
脑梗塞
治疗方案
药物经济学
成本-效果分析
cerebral infarction
therapeutic scheme
pharmacoeconomics
cost-effectiveness analysis
